STOCK TITAN

Penumbra, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference

Penumbra, Inc. (NYSE: PEN) announced its participation in the 40th Annual J.P.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Rhea-AI Summary

Penumbra, Inc. (NYSE: PEN) announced its participation in the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022. The management team will present at 11:15 AM ET (8:15 AM PT). Interested investors can access an audio webcast of the presentation through the company's website, available for at least two weeks post-event. Penumbra is dedicated to innovative healthcare solutions, serving providers in over 100 countries.

Loading...
Loading translation...
Argus Session date unavailable
+1.65% session move Open Argus
Details

News Market Reaction – PEN

The recorded move for PEN in the trading session of this news was +1.65%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

ALAMEDA, Calif., Dec. 22, 2021 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022.

Event:  40th Annual J.P. Morgan Healthcare Conference
Date:  Tuesday, January 11, 2022
Time:  11:15am ET /8:15am PT

An audio webcast of the presentation will be available by visiting the investors' section of the company's website at www.penumbrainc.com. The audio webcast will be available on the company's website for at least two weeks following the event.

About Penumbra
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra supports healthcare providers, hospitals and clinics in more than 100 countries. The Penumbra logo is a trademark of Penumbra, Inc. For more information, visit www.penumbrainc.com.

Investor Relations 
Penumbra, Inc.
510-995-2461
investors@penumbrainc.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-the-40th-annual-jp-morgan-healthcare-conference-301449956.html

SOURCE Penumbra, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Penumbra's presentation at the J.P. Morgan Healthcare Conference?

Penumbra's presentation is scheduled for January 11, 2022, at 11:15 AM ET.

Where can I watch Penumbra's presentation from the J.P. Morgan Healthcare Conference?

The presentation can be watched via an audio webcast on Penumbra's website.

What is the significance of the J.P. Morgan Healthcare Conference for Penumbra?

The conference is a key event for Penumbra to showcase its innovative therapies to investors and healthcare professionals.

What does Penumbra do?

Penumbra focuses on designing and developing innovative medical therapies for challenging medical conditions.

How many countries does Penumbra serve?

Penumbra supports healthcare providers in over 100 countries worldwide.

Keep reading